Medicare Enrolled
Dr. Samer Suki, MD
Hematology & Oncology · Kingwood, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Suki from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Suki? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Suki
Dr. Samer Suki is a hematology & oncology in Kingwood, TX, with 20 years in practice. Based on federal Medicare data, Dr. Suki performed 183,383 Medicare services across 1,902 unique beneficiaries.
Between the years covered by Open Payments, Dr. Suki received a total of $17,910 from 97 pharmaceutical and/or device companies across 821 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Suki is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in TX$ $17,910 industry payments
Medicare Practice Summary
Medicare Utilization ↗183,383
Medicare services
Top 2% in TX for hematology & oncology
1,902
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,169 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 54,750 | $1 | $3 |
| Filgrastim injection (Nivestym) for white blood cells | 39,000 | $0 | $1 |
| Pembrolizumab injection (Keytruda) | 18,000 | $43 | $131 |
| Anti-nausea injection (fosaprepitant) | 16,800 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 12,840 | $19 | $55 |
| MRI contrast dye injection (gadoterate) | 11,900 | $0 | $0 |
| Contrast dye for imaging (iodine-based) | 9,700 | $0 | $0 |
| Darbepoetin injection (Aranesp) for anemia | 8,800 | $2 | $8 |
| Flow cytometry, additional marker | 2,269 | $19 | $63 |
| Dexamethasone injection (steroid) | 2,070 | $0 | $0 |
| Office visit, established patient (30-39 min) | 1,585 | $91 | $346 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,240 | $1 | $7 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 783 | $23 | $82 |
| Anti-nausea injection (ondansetron/Zofran) | 768 | $0 | $0 |
| Administration of chemotherapy into vein, 1 hour or less | 511 | $101 | $375 |
| Drug injection, under skin or into muscle | 479 | $11 | $38 |
| Administration of chemotherapy into vein, each additional hour | 304 | $22 | $80 |
| Injection, diphenhydramine hcl, up to 50 mg | 207 | $1 | $3 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 169 | $1,161 | $5,549 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 151 | $110 | $295 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 137 | $47 | $179 |
| Administration of additional new drug or substance into vein, 1 hour or less | 117 | $51 | $183 |
| Flow cytometry technique for dna or cell analysis, first marker | 93 | $59 | $192 |
| New patient office visit (45-59 min) | 88 | $116 | $450 |
| Injection of additional new drug or substance into vein | 81 | $12 | $44 |
| Irrigation of implanted venous access drug delivery device | 69 | $19 | $73 |
| Ct scan of chest before and after contrast | 54 | $81 | $512 |
| Office visit, established patient (20-29 min) | 50 | $68 | $247 |
| Ct scan of abdomen and pelvis before and after contrast | 48 | $203 | $892 |
| Drawing of blood for a medical problem | 43 | $68 | $277 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 39 | $135 | $479 |
| Complete ultrasound scan of abdomen | 39 | $60 | $280 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 31 | $112 | $506 |
| Mri scan of brain before and after contrast | 29 | $159 | $850 |
| CT scan of chest, without contrast | 26 | $59 | $325 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $18 | $61 |
| Infusion into a vein for hydration, each additional hour | 22 | $10 | $36 |
| Mri scan of abdomen before and after contrast | 21 | $190 | $900 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $26 | $148 |
| Initial hospital admission, high complexity | 15 | $140 | $488 |
| Ct scan of blood vessels of chest with contrast | 13 | $138 | $610 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
30.4% high complexity
67.2% medium
2.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$17,910
Total received (2018-2024)
Avg $2,559/year across 7 years
Top 23% in TX for hematology & oncology
97
Companies
821
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,168 (95.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$742 (4.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$3,351
2023$3,486
2022$3,284
2021$1,907
2020$1,366
2019$2,546
2018$1,970
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
US Oncology Corporate, Inc.
$2,452
Janssen Biotech, Inc.
$1,022
PFIZER INC.
$1,012
Novartis Pharmaceuticals Corporation
$903
E.R. Squibb & Sons, L.L.C.
$790
Astellas Pharma US Inc
$713
Amgen Inc.
$654
GENZYME CORPORATION
$590
Eisai Inc.
$484
GlaxoSmithKline, LLC.
$454
Daiichi Sankyo Inc.
$446
AstraZeneca Pharmaceuticals LP
$446
Celgene Corporation
$434
Pharmacyclics LLC, An AbbVie Company
$376
Genentech USA, Inc.
$375
Takeda Pharmaceuticals U.S.A., Inc.
$333
Gilead Sciences, Inc.
$330
Karyopharm Therapeutics Inc.
$260
EISAI INC.
$256
ABBVIE INC.
$243
AbbVie Inc.
$233
Lilly USA, LLC
$230
Incyte Corporation
$219
Boehringer Ingelheim Pharmaceuticals, Inc.
$206
Puma Biotechnology, Inc.
$202
Merck Sharp & Dohme Corporation
$200
SpringWorks Therapeutics, Inc.
$157
Janssen Pharmaceuticals, Inc
$142
Mirati Therapeutics, Inc.
$140
Verastem, Inc.
$139
SOBI, INC
$138
JAZZ PHARMACEUTICALS INC.
$136
OnMark, Inc.
$134
BeiGene USA, Inc.
$127
McKesson Specialty Care Distribution, LLC
$123
Cardinal Health 110 LLC
$122
Teva Pharmaceuticals USA, Inc.
$104
AVEO Pharmaceuticals, Inc.
$99
Taiho Oncology, Inc.
$92
Stemline Therapeutics Inc.
$87
Seagen Inc.
$84
Regeneron Healthcare Solutions, Inc.
$80
Exelixis Inc.
$79
Agios Pharmaceuticals, Inc.
$78
Rigel Pharmaceuticals, Inc.
$76
Adaptive Biotechnologies Corporation
$76
ARRAY BIOPHARMA INC
$72
TerSera Therapeutics LLC
$72
Ipsen Biopharmaceuticals, Inc
$71
Lexicon Pharmaceuticals, Inc.
$71
PharmaEssentia USA Corporation
$70
Blueprint Medicines Corporation
$69
PUMA BIOTECHNOLOGY, INC.
$64
Kite Pharma, Inc.
$60
Dendreon Pharmaceuticals LLC
$55
Varian Medical Systems, Inc.
$54
Bayer HealthCare Pharmaceuticals Inc.
$52
Dova Pharmaceuticals
$50
Spectrum Pharmaceuticals Inc.
$49
ADC Therapeutics America, Inc.
$47
CTI BioPharma Corp.
$46
TESARO, Inc.
$44
McKesson Drug Company LLC
$43
Tempus AI, Inc
$43
Secura Bio, Inc.
$42
SERVIER PHARMACEUTICALS LLC
$42
EMD Serono, Inc.
$41
Nestle HealthCare Nutrition Inc.
$40
Deciphera Pharmaceuticals Inc.
$40
SUN PHARMACEUTICAL INDUSTRIES INC.
$39
Merck Sharp & Dohme LLC
$31
Apellis Pharmaceuticals, Inc.
$30
TOLMAR Pharmaceuticals, Inc.
$27
Sobi, Inc
$26
Inari Medical, Inc.
$26
Seattle Genetics, Inc.
$25
Foundation Medicine, Inc.
$25
MEDIVATION FIELD SOLUTIONS LLC
$24
Pharmacosmos Therapeutics Inc.
$24
Bayer Healthcare Pharmaceuticals Inc.
$23
SANOFI-AVENTIS U.S. LLC
$23
Servier Pharmaceuticals LLC
$22
Pharming Healthcare, Inc.
$21
Pharmacyclics LLC, an AbbVie Company
$20
Aveo Pharmaceuticals, Inc.
$20
MorphoSys, US Inc.
$20
Sandoz Inc.
$20
EUSA Pharma (US) LLC
$19
Sirtex Medical Inc
$19
TAIHO ONCOLOGY, INC.
$18
Genmab U.S., Inc.
$16
Mylan Institutional Inc.
$15
Myovant Sciences Inc.
$14
AMAG Pharmaceuticals, Inc.
$14
Kyowa Kirin, Inc.
$14
Epizyme, Inc.,
$13
Acrotech Biopharma LLC
$12
Top 3 companies account for 25.0% of total payments
Associated products mentioned in payments ›
ABECMA · ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AVYCAZ · AYVAKIT · Alecensa · Aranesp · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CARVYKTI · CHANTIX · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Copiktra · DALVANCE · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMEND · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Empaveli · Enhertu · Erleada · FARYDAK · FERAHEME · FLOWTRIEVER CATHETER · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · Folotyn · Fulphila · GAVRETO · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · INQOVI · INREBIC · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · ORGOVYX · Orserdu · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · ROLVEDON · RUCONEST · RYBREVANT · RYDAPT · Revlimid · Rezlidhia · S · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TEFLARO · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · ZARXIO · ZEJULA · ZENPEP · ZEPZELCA · ZOLADEX · ZYTIGA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $10 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
41
Per 100K population
0.9
County median income
$73,104
Nearest hospital
KINGWOOD PINES HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Suki is a mixed practice specialist, with above-average Medicare volume (top 2% in TX), and low-engagement industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Suki experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Suki performed 54,750 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Suki receive payments from pharmaceutical companies?
Yes. Dr. Suki received a total of $17,910 from 97 companies across 821 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Suki's costs compare to other hematology & oncologys in Kingwood?
Dr. Suki's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Suki) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Kingwood
Browse hematology & oncologys in Kingwood ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
US Oncology Corporate, Inc. Payments to Doctors
See all physicians who received payments from US Oncology Corporate, Inc..
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology